[68Ga]Ga-NODAGA-SNA014

N/A

Report date: 2025/09/19 16:19:14

Base Information

Drug Name[68Ga]Ga-NODAGA-SNA014
Drug Alias Name68Ga labeled Claudin 18.2-SNA014[68Ga]Ga-NODAGA-SNA014SNA-01468Ga-SNA014
ClassificationDiagnostic agent (In vivo) > Contrast agentRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68Ga +[4] 
Mechanisms of ActionPositron-emission tomography enhancersClaudin 18 protein modulatorsDiagnostic imaging enhancers +[4] 
TargetsClaudin-18 splice variant 2
Therapy Area/IndicationsPancreatic NeoplasmsAdenocarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSmartnuclide Biopharma
China Registration ClassN/A

Develop Information

Active CompaniesSmartnuclide Biopharma
Inactive CompaniesN/A
Active IndicationsPancreatic NeoplasmsAdenocarcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A